scholarly article | Q13442814 |
P356 | DOI | 10.1210/JC.2010-0340 |
P698 | PubMed publication ID | 20534758 |
P50 | author | Alan Schwartz | Q37831141 |
Andrea Tinelli | Q42335546 | ||
Roberto Negro | Q43037215 | ||
Alex Stagnaro-Green | Q43037232 | ||
P2093 | author name string | Riccardo Gismondi | |
Tiziana Mangieri | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | human pregnancy | Q11995 |
miscarriage | Q28693 | ||
antibody | Q79460 | ||
P304 | page(s) | E44-8 | |
P577 | publication date | 2010-06-09 | |
P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
P1476 | title | Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy | |
P478 | volume | 95 |
Q33944124 | 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. |
Q90014943 | A hidden cause of infertility in hypothyroid patients |
Q35646920 | A national survey on public perceptions of miscarriage. |
Q40227828 | Association between the clinical classification of hypothyroidism and reduced TSH in LT4 supplemental replacement treatment for pregnancy in China |
Q52571440 | Circulating MicroRNA Profile as a Potential Predictive Biomarker for Early Diagnosis of Spontaneous Abortion in Patients With Subclinical Hypothyroidism. |
Q37668431 | Correlation of enhanced oxidative stress with altered thyroid profile: Probable role in spontaneous abortion |
Q38990879 | Current challenges in the pharmacological management of thyroid dysfunction in pregnancy. |
Q46908515 | Do elevated TSH levels predict early pregnancy loss in ART patients? |
Q36084882 | Early Phthalates Exposure in Pregnant Women Is Associated with Alteration of Thyroid Hormones |
Q47161714 | Early pregnancy thyroid hormone reference ranges in Chilean women: the influence of body mass index. |
Q58748644 | Effect of mildly elevated thyroid-stimulating hormone during the first trimester on adverse pregnancy outcomes |
Q92757636 | Effect of moderately increased thyroid-stimulating hormone levels and presence of thyroid antibodies on pregnancy among infertile women |
Q37081142 | Effects of Levothyroxine Therapy on Pregnancy Outcomes in Women with Subclinical Hypothyroidism |
Q50940268 | Effects of perfluorinated chemicals on thyroid function, markers of ovarian reserve, and natural fertility. |
Q36794012 | Endocrine dysfunction and recurrent spontaneous abortion: An overview |
Q44837970 | Establishing trimester-specific maternal thyroid function reference intervals |
Q53629364 | Etiology of spontaneous abortion before and after the demonstration of embryonic cardiac activity in women with recurrent spontaneous abortion. |
Q35622811 | Feto-maternal Outcome Using New Screening Criteria of Serum TSH for Diagnosing Hypothyroidism in Pregnancy |
Q92130873 | Five serum fatty acids are associated with subclinical hypothyroidism in a Chinese pregnant population |
Q35738765 | Further evidence on the role of thyroid autoimmunity in women with recurrent miscarriage |
Q24628836 | Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum |
Q36930719 | High prevalence of subclinical hypothyroidism during first trimester of pregnancy in North India |
Q49617213 | Higher TSH Levels Within the Normal Range Are Associated With Unexplained Infertility |
Q35967753 | Hypothyroidism in pregnancy |
Q87429515 | Hypothyroidism in pregnancy |
Q48267677 | Impact of borderline-subclinical hypothyroidism on subsequent pregnancy outcome in women with unexplained recurrent pregnancy loss. |
Q64095758 | Impact of subclinical hypothyroidism and thyroid autoimmunity on clinical pregnancy rate after intrauterine insemination in euthyroid women |
Q64929751 | Implantation failure in rats with subclinical hypothyroidism is associated with LIF/STAT3 signaling. |
Q57170489 | Influencing factors of pregnancy loss and survival probability of clinical pregnancies conceived through assisted reproductive technology |
Q87038402 | Knowledge, attitudes and behaviors of physicians towards thyroid disorders and iodine requirements in pregnancy |
Q35184548 | Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen. |
Q26765262 | Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits |
Q36767568 | Local and systemic factors and implantation: what is the evidence? |
Q37290825 | Management of subclinical hypothyroidism: the thyroidologists' view |
Q90125633 | Maternal TSH levels at first trimester and subsequent spontaneous miscarriage: a nested case-control study |
Q94464326 | Maternal Thyroid Dysfunction and Gestational Anemia Risk: Meta-Analysis and New Data |
Q37286956 | Maternal screening for hypothyroidism and thyroiditis using filter paper specimens |
Q34499870 | Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study |
Q40845746 | Maternal thyroid function in pregnancy may program offspring blood pressure, but not adiposity at 20 y of age. |
Q58612268 | Meta-analysis of ART outcomes in women with different preconception TSH levels |
Q34784972 | New insights into mechanisms behind miscarriage |
Q92215271 | Novel high-coverage targeted metabolomics method (SWATHtoMRM) for exploring follicular fluid metabolome alterations in women with recurrent spontaneous abortion undergoing in vitro fertilization |
Q38247059 | Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy. |
Q30234769 | Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis |
Q40221860 | Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure |
Q42138515 | Postpartum Follow-up in Women Diagnosed with Subclinical Hypothyroidism during Pregnancy |
Q38906859 | Preconception TSH and pregnancy outcomes: a population-based cohort study in 184 611 women. |
Q64083160 | Pregnancy Loss and Iodine Status: The LIFE Prospective Cohort Study |
Q38191709 | Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome? |
Q33815541 | Prevalence of Thyroid Peroxidase Antibody and Pregnancy Outcome in Euthyroid Autoimmune Positive Pregnant Women from a Tertiary Care Center in Haryana |
Q55471416 | Prevalence of subclinical hypothyroidism in pregnancy in Saudi Arabia. |
Q83386958 | Re-thinking the definitions of subclinical thyroid disease in pregnancy |
Q36697714 | Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013). |
Q51300684 | Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases. |
Q57825128 | Reference intervals for thyroid markers in early pregnancy determined by 7 different analytical systems |
Q26768622 | Reporting Thyroid Function Tests in Pregnancy |
Q38300824 | Reversible morbidity markers in subclinical hypothyroidism |
Q51785954 | Screening for thyroid dysfunction during the second trimester of pregnancy. |
Q48271628 | Secondary and tertiary preventions of thyroid disease |
Q38535361 | Should all women be screened for thyroid dysfunction in pregnancy? |
Q36965286 | Subclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live Birth |
Q35912431 | Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis |
Q55054302 | Subclinical Hypothyroidism in Women Planning Conception and During Pregnancy: Who Should Be Treated and How? |
Q36657473 | Subclinical hypothyroidism in pregnancy: An emerging problem in Southern West Bengal: A cross-sectional study |
Q53174703 | TSH reference values in the first trimester of gestation and correlation between maternal TSH and obstetric and neonatal outcomes: a prospective Brazilian study. |
Q34294814 | Teratology public affairs committee position paper: iodine deficiency in pregnancy |
Q37837503 | The TSH upper reference limit: where are we at? |
Q37360481 | The debate on treating subclinical hypothyroidism |
Q38835277 | The effect of oil and water-soluble contrast medium in hysterosalpingography on thyroid function |
Q47100356 | The impact of elevated thyroid stimulating hormone on female subfertility |
Q35646080 | The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve: a case-control study |
Q37689167 | The impact of thyroid function on intrauterine insemination outcome--a retrospective analysis |
Q38056040 | Thyroid (dys-)function in normal and disturbed pregnancy |
Q40492427 | Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming. |
Q55315584 | Thyroid Function in Pregnant Women With Moderate to Severe Alcohol Consumption Is Related to Infant Developmental Outcomes. |
Q35038902 | Thyroid antibodies and miscarriage: where are we at a generation later? |
Q59742907 | Thyroid disorders in pregnancy |
Q34289817 | Thyroid function in pregnancy |
Q90738081 | Thyroid hormone therapy of hypothyroidism in pregnancy |
Q22305857 | Treatment for primary hypothyroidism: current approaches and future possibilities |
Q33598465 | Triiodothyronine regulates angiogenic growth factor and cytokine secretion by isolated human decidual cells in a cell-type specific and gestational age-dependent manner. |
Q38530405 | Unsolved Mysteries of the Human Mammary Gland: Defining and Redefining the Critical Questions from the Lactation Consultant's Perspective |
Q36284454 | Urinary iodine in early pregnancy is associated with subclinical hypothyroidism in Tianjin, China: an observational study |
Search more.